SCHEMBL20184801

SCHEMBL20184801

Fc1ccc(N=C=Nc2ccc(F)cc2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC22A2 O15244 1/20 0.44
SLC22A1 O15245 1/20 0.44
SLC22A3 O75751 1/20 0.44
PLAU P00749 1/20 0.44
NOS3 P29474 2/20 0.42
NOS1 P29475 2/20 0.42
ESR1 P03372 1/20 0.37
ESR2 Q92731 1/20 0.37
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
CA7 P43166 1/20 0.36
CA9 Q16790 1/20 0.36
ACHE P22303 1/20 0.36
MIF P14174 1/20 0.34
HSP90AA1 P07900 1/20 0.34
MAPT P10636 2/20 0.32
ALDH1A1 P00352 1/20 0.32
MPI P34949 1/20 0.32
CYP3A4 P08684 1/20 0.32
TSHR P16473 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25305038 0.78 SLC22A2 (0.41) SLC22A2SLC22A1SLC22A3PLAUNOS3
SCHEMBL28187996 0.78 SLC22A2 (0.41) SLC22A2SLC22A1SLC22A3PLAUNOS3
SCHEMBL457225 0.78 MIF (0.56) SLC22A2SLC22A1SLC22A3PLAUNOS3
SCHEMBL93163 0.78 CYP3A4 (0.56) SLC22A2SLC22A1SLC22A3PLAUNOS3
SCHEMBL5862066 0.72 CYP3A4 (0.50) SLC22A2SLC22A1SLC22A3PLAUNOS3
SCHEMBL5114953 0.71 SLC22A2 (0.50) SLC22A2SLC22A1SLC22A3PLAUNOS3
SCHEMBL5114955 0.71 SLC22A2 (0.50) SLC22A2SLC22A1SLC22A3PLAUNOS3
SCHEMBL3181838 0.71 SLC22A2 (0.50) SLC22A2SLC22A1SLC22A3PLAUNOS3
Fluorobenzene SCHEMBL2828466 0.71 CYP3A4 (0.48) SLC22A2SLC22A1SLC22A3PLAUNOS3
SCHEMBL507594 0.71 MAPT (0.55) NOS3NOS1CA2CA9ACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3327002-B1 ACID-RESISTANT BASE AND/OR RADICAL GENERATOR, AND CURABLE RESIN COMPOSITION CONTAINING SAID BASE AND/OR RADICAL GENERATOR FUJIFILM WAKO PURE CHEMICAL CORP (JP) 2020-08-19 EP disclosed
CN-107473991-B Method for synthesizing isourea catalyzed by rare earth compound 苏州大学 2020-04-10 CN disclosed
US-10428015-B2 Acid-resistant base and/or radical generator, and curable resin composition containing said base and/or radical generator FUJIFILM WAKO PURE CHEMICAL CORPORATION (JP) 2019-10-01 US disclosed
US-20190002403-A1 ACID-RESISTANT BASE AND/OR RADICAL GENERATOR, AND CURABLE RESIN COMPOSITION CONTAINING SAID BASE AND/OR RADICAL GENERATOR FUJIFILM WAKO PURE CHEMICAL CORPORATION (JP) 2019-01-03 US disclosed
EP-3327002-A1 ACID-RESISTANT BASE AND/OR RADICAL GENERATOR, AND CURABLE RESIN COMPOSITION CONTAINING SAID BASE AND/OR RADICAL GENERATOR Wako Pure Chemical Industries, Ltd. (JP) 2018-05-30 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10428015-B2 Acid-resistant base and/or radical generator, and curable resin composition containing said base and/or radical generator REV1, RER1, CBR1 SLC22A2 2855/4885SLC22A1 2571/4885SLC22A3 2970/4885
US-20190002403-A1 ACID-RESISTANT BASE AND/OR RADICAL GENERATOR, AND CURABLE RESIN COMPOSITION CONTAINING SAID BASE AND/OR RADICAL GENERATOR REV1, RER1, CBR1 SLC22A2 2855/4885SLC22A1 2571/4885SLC22A3 2970/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.